Live Breaking News & Updates on Flexitab Breakable Extended Release Tablets

Stay updated with breaking news from Flexitab breakable extended release tablets. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

DGAP-News: Altus Formulation Inc.: Altus Formulation Announces Allowance of New Flexitab Technology Patent in USA


DGAP-News: Altus Formulation Inc.: Altus Formulation Announces Allowance of New Flexitab Technology Patent in USA
vom 15.04.2021, 13:00 Uhr
Bild: pixabay.com
Altus Formulation Inc.: Altus Formulation Announces Allowance of New Flexitab Technology Patent in USA
15.04.2021 / 13:00
Altus Formulation Announces Allowance of New Flexitab Technology Patent in USA
New USA Patent Complements Existing Global Flexitab Portfolio
LAVAL, QC / ACCESSWIRE / April 15, 2021 / Altus Formulation Inc. ( Altus ) today announced that its patent application US 2020029785 covering all Flexitab Breakable Extended Release Tablets has been allowed by the United States Patent and Trademark Office. The new patent is expected to provide protection to Flexitab products in the USA until 2038. ....

United States , M Robert Bechard , Damon Smith , Altu Trazoflex , Trademark Office , Corporate Development , Altus Formulation Inc , Distribution Services , Altus Formulation , Formulation Inc , Altus Formulation Announces Allowance , New Flexitab Technology Patent , Formulation Announces Allowance , Flexitab Breakable Extended Release Tablets , United States Patent , Robert Bechard , Corporate News , Regulatory Announcements , ஒன்றுபட்டது மாநிலங்களில் , மீ ராபர்ட் பெச்சார்ட் , டாமன் ஸ்மித் , முத்திரை அலுவலகம் , பெருநிறுவன வளர்ச்சி , அல்டஸ் உருவாக்கம் இன்க் , விநியோகம் சேவைகள் , அல்டஸ் உருவாக்கம் ,

Altus Formulation Inc.: Altus Formulation Announces Allowance of New Flexitab Technology Patent in USA


Altus Formulation Inc.: Altus Formulation Announces Allowance of New Flexitab Technology Patent in USA
New USA Patent Complements Existing Global Flexitab Portfolio
LAVAL, QC / ACCESSWIRE / April 15, 2021 / Altus Formulation Inc. ( Altus ) today announced that its patent application US 2020029785 covering all Flexitab Breakable Extended Release Tablets has been allowed by the United States Patent and Trademark Office. The new patent is expected to provide protection to Flexitab products in the USA until 2038.
Speaking about the new patent Dr. Damon Smith CEO of Altus said; We are very pleased to have achieved this major milestone for Flexitab technology so quickly, providing as it does a further 12 years of patent coverage to Altus TrazoFlex, TramaFlex and AcetraFlex late stage opportunities . He added; There are many titration sensitive drugs on the market today especially in the CNS space. Flexitab s ability to generate multiple extended-release doses from a sing ....

United States , M Robert Bechard , Kostenloser Wertpapierhandel , Damon Smith , Altu Trazoflex , Trademark Office , Corporate Development , Altus Formulation Inc , Altus Formulation , Flexitab Breakable Extended Release Tablets , United States Patent , Robert Bechard , ஒன்றுபட்டது மாநிலங்களில் , மீ ராபர்ட் பெச்சார்ட் , டாமன் ஸ்மித் , முத்திரை அலுவலகம் , பெருநிறுவன வளர்ச்சி , அல்டஸ் உருவாக்கம் இன்க் , அல்டஸ் உருவாக்கம் , ஒன்றுபட்டது மாநிலங்களில் காப்புரிமை , ராபர்ட் பெச்சார்ட் ,